HCPCS code J9381 — Inj teplizumab mzwv 5 mcg. Status: Active. Effective Jul 1, 2023. Source: CMS HCPCS Level II.

J9381

Active

Inj teplizumab mzwv 5 mcg

Injection, teplizumab-mzwv, 5 mcg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jul 1, 2023
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9112

MUE — Medically Unlikely Edits

Maximum units of J9381 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 800
Practitioner Services 800

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
73650-0316-01 Tzield
73650-0316-10 Tzield
73650-0316-14 Tzield

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2023-Q3
    Inj teplizumab mzwv 5 mcg